Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023-Reference-Cited by-同舟云学术

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023

Published:2024-02 Issue: Volume:85 Page:101745
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Cavaleri Marco,Kaslow David^ORCID,Boateng Eric,Chen Wilbur H.^ORCID,Chiu Christopher^ORCID,Choy Robert K.M.,Correa-Oliveira Rodrigo,Durbin Anna^ORCID,Egesa Moses^ORCID,Gibani Malick^ORCID,Kapulu Melissa^ORCID,Katindi Melba,Olotu Ally,Pongsuwan Pongphaya,Simuyandi Michelo,Speder Bruno,Talaat Kawsar R.^ORCID,Weller Charlie,Wills Bridget^ORCID,Baay Marc^ORCID,Balasingam Shobana,Olesen Ole F.^ORCID,Neels Pieter

Funder

Bill & Melinda Gates Foundation

Wellcome Trust

Innovative Medicines Initiative

Publisher

Elsevier BV

Reference13 articles.

1. Human challenge trials in vaccine development: strasbourg, September 29 - October 1, 2014;Sheets;Biologicals,2016

2. Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017;Baay;Biologicals,2019

3. Human challenge trial workshop: focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019;Bekeredjian-Ding;Biologicals,2020

4. Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report;Pollard;Biologicals,2020

5. SARS-CoV-2 controlled human infection models: ethics, challenge agent production and regulatory issues;Baay;Biologicals,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross‐disciplinary mathematical modelling to benefit healthcare – could clinical pharmacology play an enabling role?;British Journal of Clinical Pharmacology;2024-07-31